Cas no for 198470-85-8,PARECOXIB SODIUM ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich

Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

Home > CAS No. Inquiry > 198470-85-8

198470-85-8

[CAS Name] PARECOXIB SODIUM

[Formula] C19H18N2O4S.Na

Search Products Post Sourcing Request

Basica Info

[CAS Name]PARECOXIB SODIUM
[Alias]N-[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL)PHENYLSULFONYL]PROPIONAMIDE, SODIUM SALT;Parecoxib sodiuM salt;Dynastat;N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanaMide SodiuM Salt;Rayzon;SC 69124A
[Number]198470-85-8
[EINECS]
[Formula]C19H18N2O4S.Na
[Molecular weight]392.4

[Melting point]273-275°C

198470-85-8 Suppliers

Company

Main Products

Shandong Loncom Pharmaceutical Co.Ltd.

Product Name: PARECOXIB SODIUM

Synonyms: Parecoxib sodium (Intermediate in China ONLY);N-[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL)PHENYLSULFONYL]PROPIONAMIDE, SODIUM SALT;Parecoxib sodiuM salt;Dynastat;N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanaMide SodiuM Salt;Rayzon;SC 69124A;PropanaMide,N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-, sodiuM salt (1:1)

CAS: 198470-85-8

MF: C19H19N2NaO4S

MW: 394.42

Melting point: 273-275°C

storage temp.: Inert atmosphere,2-8°C

Parecoxib is a water-soluble and injectable prodrug of valdecoxib. It is marketed as Dynastat in the European Union. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib (Celebrex) and rofecoxib (Vioxx). As it is injectable, it can be used perioperatively when patients are unable to take oral medications. It is approved through much of Europe for short term perioperative pain control much in the same way ketorolac (Toradol) is used in the United States. A letter of non-approval for parecoxib was issued by the FDA in 2005.

Send Inquiry

Sichuan Omnis Pharmaceutical Co., Ltd.

Currently Parecoxib sodium is under development, and estimated to market in the end of 2019.

Send Inquiry

YaoPu(Shanghai)Pharmaceutical Technology Co.,Ltd

Chemical Name	N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide Sodium Salt
Formula	C₁₉H₁₇N₂NaO₄S
M.w.	392.40
CAS#	198470-85-8
Properties	White to off-white powder
Indication	Treatment of moderate or severe postoperative acute pain, ANTIOXIN drugs in antiarthritis drugs.